Table 5.
Major congenital malformationsb |
Apgar 5 Min (<7) | Ventilation/CPAPc | NICUd | Jaundice | Birth Lengthe | Head Circumferencee |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome n (%): | 190 (4.4) | 41 (1.0) | 139 (3.3) | 519 (12.3) | 1230 (28.8) | 338 (8.0) | 576 (14.0) | |||||||
Adjusted estimates: | aOR | 95% CI | aOR | 95% CI | aOR | 95% CI | aOR | 95% CI | aOR | 95% CI | aOR | 95% CI | aOR | 95% CI |
Month 1 drinking | ||||||||||||||
None | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||||
< 0.10 oz AA/day | 0.78 | 0.40–1.50 | 1.61 | 0.67–3.84 | 1.43 | 0.89–2.31 | 1.12 | 0.86–1.46 | 1.17 | 0.97–1.42 | 1.10 | 0.78–1.54 | 1.08 | 0.83–1.42 |
0.10<0.25oz AA/day | 1.20 | 0.65–2.22 | - | NAC | 0.28 | 0.07–1.19 | 0.67 | 0.41–1.09 | 0.87 | 0.64–1.20 | 0.71 | 0.38–1.32 | 0.78 | 0.49–1.25 |
≥0.25 oz AA/day | 1.15 | 0.77–1.71 | 2.32 | 0.86–6.28 | 2.10 | 1.16–3.79 | 1.25 | 0.87–1.79 | 1.01 | 0.79–1.37 | 0.70 | 0.41–1.20 | 0.83 | 0.56–1.24 |
First Trimester drinking | ||||||||||||||
Abstinent | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||||
1st month only | 1.07 | 0.73–1.57 | 1.12 | 0.47–2.66 | 1.27 | 0.81–2.00 | 1.08 | 0.84–1.38 | 1.01 | 0.85–1.21 | 0.92 | 0.67–1.27 | 0.99 | 0.77–1.28 |
Drinking months 1–3 | 1.28 | 0.83–1.96 | 1.28 | 0.48–3.43 | 1.12 | 0.64–1.97 | 0.96 | 0.70–1.31 | 1.09 | 0.88–1.35 | 0.56 | 0.36–0.87 | 0.69 | 0.50–0.96 |
Drinking up to baseline interview | ||||||||||||||
Abstinent | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |||||||
Drinking | 1.17 | 0.86–1.60 | 1.19 | 0.59–2.40 | 1.23 | 0.84–1.80 | 0.99 | 0.81–1.23 | 1.06 | 0.92–1.23 | 0.74 | 0.56–0.97 | 0.81 | 0.66–1.01 |
Adjusted models included investigation of the following potential confounders and risk factors: parity, maternal age, education, BMI, marital status, ethnicity, caffeine, smoking, exercise, work, prenatal and multivitamin use, passive smoke exposure, marijuana use, cocaine use, study cohort, preterm labor, respiratory problem, infant gender, bleeding, nausea/vomiting, hypertension, incompetent cervix, placental problems, sexually transmitted disease, induction/augmentation, maternal asthma, gestational diabetes. Total observations included in adjusted multivariable models: Month 1 across (n=4047; n=4017; n=3988; n=3983; n=3999; n=3985; n=3892); First trimester across (n=4009; n=3979; n=3950; n=3945; n=3961; n=3947; n=3856); Drinking to baseline interview, across (n=4066; n=4036; n=4007; n=4002; n=4018; n=4003; n=3910)
Based on definition of major congenital malformations 28
Includes both ventilation and continuous positive airway pressure (CPAP)
Includes NICU observation and admission
10th percentile based on CDC 2000 growth standards 27
NAC=Not able to calculate